Currently occurring Questions (4/4)
Dear Cannerald and CannerGrow Community,
This is the last blog article of the four-part blog article series.
After the video update with the tour in the first blog article (click),
the detailed explanation of the increase in service costs in the second blog article (click),
the explanation of the importance of the meaning of the increased service costs for Cannerald and an outlook for the future in the third blog article (click),
now follows a video statement by CEO Levin Amweg on the previously frequently asked questions which he will answer transparently.
We also want to note that a comprehensive FAQ blog article will be published in the coming weeks.
Furthermore, the entire FAQ area in the CannerGrow Backoffice on the "Help" page in the main menu, where you can also reach CannerGrow Support, will be revised over the coming weeks.
In this video, Levin will address the following questions:
1. Will the company go bankrupt if there is a very likely temporary halt in production?
2. Does Severin Amweg still work at Cannerald?
3. Did the increase in employee costs in the service costs result from employee salary increases?
4. Is Cannerald still pioneering the pharmaceutical GMP THC cannabis market?
5. Statement on the current increase in hack attacks on us and fake posts about us.
Video from CEO Levin Amweg:
Attached is the document of the mutation of Cannerald GmbH to Cannerald AG:
👉🏻 Link to the official SHAB publication (click)
👉🏻 Entry of the SHAB publication also on moneyhouse.ch, if you scroll down (click)
This was additionally officially announced by our company at the beginning of July 2022.
We would like to note that our compliance team will take legal action against the increasing number of fake posts and false statements with the involvement of our legal counsel.
We think it's a shame that this is an attempt to put us in a bad light as a company, damage our reputation and even worse: attempts are made to unsettle our community and customers.
Please share our four blog article series with the entire Cannerald and CannerGrow community and take the time to check out the blog articles and videos.
We are aware that the current situation is not pleasant and would have wished it differently.
We hope we were able to give you more insight into our company, the current situation and the pharmaceutical future of Cannerald in the four-part blog article series.
Your Cannerald & CannerGrow team